Compliance Question of the Week – Pharmacy

We are hearing a lot lately about something known as DIR. Does this apply to Medicare?

Does Medicare pay pharmacists for hospital professional services?

Which revenue codes should be used to report vaccines and their administration to Medicare?

What code is assigned for Flucelvax Quadrivalent on a Medicare claim?

Last week you said that the new modifier ZC (Merck/Samsung Bioepis) would be effective on July 1, 2017 for the code reporting an injection of the biosimilar drug infliximab. However, I think that is the wrong date. Instead, it should be October 1, 2017, according to transmittal 3850. Can you verify?

What code and modifier should be used to report an injection of the biosimilar drug infliximab?

For the last quarter of 2017, are there any additional drugs with pass-through status?

Must a hospital pharmacist retain documentation for Medicare patients?

If the units of a drug given exceed the size of the units field on the claim, how should the remaining be billed?

Is Q2039 the correct code to assign to report the flu virus vaccine to Medicare?

Is it true that CMS will cut reimbursement for the 340B program in 2018?

In the urgent-care setting, for procedure codes such as 94640, would we (the hospital) still bill the J code for the appropriate drug?